SERPLUS TECHNOLOGY, LLC
Biotech · Private
Recombinant serpin B1 protein therapeutic to attenuate cytokine storm in severe respiratory viral infections
- Grants
- $948K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Amelioration of rhinovirus induced asthma exacerbations by serpin B1 | $223,334 | |
| Federal grant | Department of Health and Human Services · Phase I · Regulation of Autoimmune Type 1 Diabetes by Serpins B1 and A1 (Alpha 1-Antitrypsin) | $218,434 | |
| Federal grant | Department of Health and Human Services · Phase I · Enhanced pancreatic islet cell engraftment by treatment with serpin B1 | $246,281 | |
| Federal grant | Department of Health and Human Services · Phase I · PA-21-259, SBIR, Phase I, Serpin B1. A host-directed therapy to prevent and treat severe pulmonary influenza | $259,613 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3153 | BLOOD CELL TECHNOLOGIES LLC | — | — |
| 3154 | PETAOMICS, INC. | — | — |
| 3155 | OSEL, INC. | — | — |
| 3156 | SERPLUS TECHNOLOGY, LLC | — | — |
| 3157 | ASPIREBIO CORPORATION | — | — |
| 3158 | UNDERDOG PHARMACEUTICALS, INC. | — | — |
| 3159 | GENEXGEN INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Oxidation-resistant Serpinsapplication
- Oxidation-resistant Serpinsapplication
- Oxidation-resistant Serpinsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.